Participants
pain
Of the 21 315 participants randomised, 5 requested that their details be deleted from the database. Eighty-four percent of participants reported taking ≥80 % of the study capsules up to the end of 5 yearsFor the current analysis, we included 20 423 participants (∼96 % of both study groups) for whom at least one PIQ-6 score was available (
Flow chart of participant selection for analysis of pain.
Baseline characteristics according to randomisation groupAll the variables are self-reported other than sex, age and predicted 25(OH)D concentration.25(OH)D, 25-hydroxy vitamin D.